Type(s) of Cancer
Prostate
Prostate
Study Phase
Phase 3
Study Completion Date
2012-04
2012-04
NCT00519285Uploaded 09-19-2013
Available for Download
PDS UID: Prostat_Sanofi_2007_83
A Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of Aflibercept Versus Placebo Administered Every 3 Weeks in Patients Treated With Docetaxel/ Prednisone for Metastatic Androgen-independent Prostate Cancer
Files:![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-zip.png)
![](/projectdatasphere/Images/icons/icon-zip.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
PROTOCOLSanofi Study Protocol Venice.pdf
![](/projectdatasphere/Images/icons/icon-pdf.png)
CRFSanofi CRF Venice.pdf
![](/projectdatasphere/Images/icons/icon-zip.png)
DATA (COMPARATOR ARM)Sanofi Data Venice.zip
![](/projectdatasphere/Images/icons/icon-zip.png)
DATA (COMPARATOR ARM)Sanofi Data Descriptors Venice.zip